1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans
(
- Contribution to journal › Article
-
Mark
Structure–activity relationships of galabioside derivatives as inhibitors of E. coli and S. suis adhesins: nanomolar inhibitors of S. suis adhesins
(
- Contribution to journal › Article
- 2003
-
Mark
Role of the galactosyl moiety of collagen glycopeptides for T-cell stimulation in a model for rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides.
(
- Contribution to journal › Article
- 2002
-
Mark
Glycopeptide specificity of helper T cells obtained in mouse models for rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Discovery of potent inhibitors of PapG adhesins from uropathogenic Escherichia coli through synthesis and evaluation of galabiose derivatives
(
- Contribution to journal › Article
- 2001
-
Mark
Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli.
(
- Contribution to journal › Article
- 2000
-
Mark
Synthesis of a C-glycoside analogue of beta-D-galactosyl hydroxynorvaline and its use in immunological studies
(
- Contribution to journal › Article
-
Mark
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
(
- Contribution to journal › Article